Huntington disease: Can a zebrafish trail leave more than a ripple?

Neuroscience and Biobehavioral Reviews

Volumn 45, Issue , 2014, Pages 258-261

  Das, Sambit ^a   Rajanikant, G K ^a  

^a NATIONAL INSTITUTE OF TECHNOLOGY CALICUT   (India)

Author keywords

Huntington's disease; Model organism; Movement disorder; Zebrafish

Indexed keywords

HEAT SHOCK PROTEIN 70;

CARBOXY TERMINAL SEQUENCE; DISEASE MODEL; GENE DOSAGE; GENE MUTATION; GENE PRODUCT; GENE SEQUENCE; GENETIC MANIPULATION; HETEROZYGOTE; HUMAN; HUNTINGTON CHOREA; NONHUMAN; PROTEIN AGGREGATION; PROTEIN EXPRESSION; REVIEW; SEQUENCE HOMOLOGY; SOCIAL BEHAVIOR; START CODON; UPREGULATION; ZEBRA FISH; ANIMAL; MOTOR ACTIVITY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; HUNTINGTON DISEASE; MOTOR ACTIVITY; ZEBRAFISH;

EID: 84904429389     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2014.06.013     Document Type: Review

References (19)

1. Conforti P., Zuccato C., Gaudenzi G., Ieraci A., Camnasio S., Buckley N.J., Mutti C., Cotelli F., Contini A., Cattaneo E. Binding of the repressor complex REST-mSIN3b by small molecules restores neuronal gene transcription in Huntington's disease models. J. Neurochem. 2013, 125. [Epub ahead of print]. 10.1111/jnc.12348.
2. Diekmann H., Anichtchik O., Fleming A., Futter M., Goldsmith P., Roach A., Rubinsztein D.C. Decreased BDNF levels are a major contributor to the embryonic phenotype of huntingtin knockdown zebrafish. J. Neurosci. 2009, 29:1343-1349.
3. Goldberg Y.P., Andrew S.E., Theilmann J., Kremer B., Squitieri F., Telenius H., Brown J.D., Hayden M.R. Familial predisposition to recurrent mutations causing Huntington's disease: genetic risk to sibs of sporadic cases. J. Med. Genet. 1993, 30:987-990.
4. Harper B. Huntington disease. J. R. Soc. Med. 2005, 98:550.
5. Henshall T.L., Tucker B., Lumsden A.L., Nornes S., Lardelli M.T., Richards R.I. Selective neuronal requirement for Huntingtin in the developing zebrafish. Hum. Mol. Gen. 2009, 18:4830-4842.
6. Karlovich C.A., John R.M., Ramirez L., Stainier D.Y., Myers R.M. Characterization of the Huntington's disease (HD) gene homologue in the zebrafish Danio rerio. Gene 1998, 217:117-125.
7. Lieschke G.J., Currie P.D. Animal models of human disease: zebrafish swim into view. Nat. Rev. Genet. 2007, 8:353-367.
8. Lo Sardo V., Zuccato C., Gaudenzi G., Vitali B., Ramos C., Tartari M., Myre M.A., Walker J.A., Pistocchi A., Conti L., Valenza M., Drung B., Schmidt B., Gusella J., Zeitlin S., Cotelli F., Cattaneo E. An evolutionary recent neuroepithelial cell adhesion function of huntingtin implicates ADAM10-Ncadherin. Nat. Neurosci. 2012, 15:713-721.
9. Lumsden A.L., Henshall T.L., Dayan S., Lardelli M.T., Richards R.I. Huntingtin-deficient zebrafish exhibit defects in iron utilization and development. Hum. Mol. Gen. 2007, 16:1905-1920.
10. Miller V.M., Nelson R.F., Gouvion C.M., Williams A., Rodriguez-Lebron E., Harper S.Q., Davidson B.L., Rebagliati M.R., Paulson H.L. CHIP suppresses polyglutamine aggregation and toxicity in vitro and in vivo. J. Neurosci. 2005, 25:9152-9161.
11. Myers R.H., MacDonald M.E., Koroshetz W.J., Duyao M.P., Ambrose C.M., Taylor S.A., Barnes G., Srinidhi J., Lin C.S., Whaley W.L., Lazzarini A.M., Schwarz M., Wolff G., Bird E.D., Vonsattel J.P.G., Gusella J.F. De novo expansion of a (CAG)n repeat in sporadic Huntington's disease. Nat. Genet. 1993, 5:168-173.
12. Schiffer N.W., Broadley S.A., Hirschberger T., Tavan P., Kretzschmar H.A., Giese A., Haass C., Hartl F.U., Schmid B. Identification of anti-prion compounds as efficient inhibitors of polyglutamine protein aggregation in a zebrafish model. J. Biol. Chem. 2007, 282:9195-9203.
13. Vonsattel J.P., Myers R.H., Stevens T.J., Ferrante R.J., Bird E.D., Richardson E.P. Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 1985, 44:559-577.
14. Walker F.O. Huntington's disease. Lancet 2007, 369:218-228.
15. Williams A., Sarkar S., Cuddon P., Ttofi E.K., Saiki S., Siddiqi F.H., Jahreiss L., Fleming A., Pask D., Goldsmith P., O'Kane C.J., Floto R.A., Rubinsztein D.C. Novel targets for Huntington's disease in an mTOR-independent autophagy pathway. Nat. Chem. Biol. 2008, 4:295-305.
16. Zuccato C., Cattaneo E. Role of brain-derived neurotrophic factor in Huntington's disease. Prog. Neurobiol. 2007, 81:294-330.
17. Zuccato C., Ciammola A., Rigamonti D., Leavitt B.R., Goffredo D., Conti L., MacDonald M.E., Friedlander R.M., Silani V., Hayden M.R., Timmusk T., Sipione S., Cattaneo E. Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease. Science 2001, 293:493-498.
18. Zuccato C., Liber D., Ramos C., Tarditi A., Rigamonti D., Tartari M., Valenza M., Cattaneo E. Progressive loss of BDNF in a mouse model of Huntington's disease and rescue by BDNF delivery. Pharmacol. Res. 2005, 52:133-139.
19. Zuccato C., Tartari M., Crotti A., Goffredo D., Valenza M., Conti L., Cataudella T., Leavitt B.R., Hayden M.R., Timmusk T., Rigamonti D., Cattaneo E. Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat. Genet. 2003, 35:76-83.